Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-12G (sirolimus gel) for Angiofibroma in Tuberous Sclerosis Complex
NCT02634931Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Dec 2015
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in tuberous sclerosis complex (TSC), sponsored by Nobelpharma Co., Ltd.. Started Dec 2015; status: completed.
02
Drugs
sirolimus
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NCT02634931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634931.